Differential expression of vascular cell adhesion molecule mRNA and protein in nasal mucosa in response to IL-1 or tumor necrosis factor

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 2, 1996, Pages 662-671

  Weinberger, Mark S ^a   Davidson, Terence M ^a   Broide, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

IL 1; intercellular adhesion molecule; Nasal mucosa; tumor necrosis factor; vascular cell adhesion molecule

Indexed keywords

INTERLEUKIN 1; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGY; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION;

EID: 0030025828     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70312-3     Document Type: Article

References (40)

1. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;324:1110-8.
2. Broide DH, Paine M, Firestein GS. Eosinophils express IL-5 and GM-CSF mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-24.
3. Moqbel R, Hamid Q, Ying S, et al. Expression of mRNA and immunoreactivity for the granulocyte/macrophage-colony stimulating factor (GM-CSF) in activated human eosinophils. J Exp Med 1991;174:749-52.
4. Broide DH, Gleich GJ, Cuomo A, et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J ALLERGY CLIN IMMUNOL 1991;88: 637-48.
5. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993;8:349-55.
6. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol 1994:2153-60.
7. Smart SJ, Casale TB. TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 1994;266:L238-45.
8. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to enothelium. Association with expression of VCAM-1. J Immunol 1992;148:1086-92.
9. Weller PF, Rand TH, Goelz SE, Chi-Rosso G, Lobb RR. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:7430-3.
10. Dobrina A, Menegazzi R, Carlos TM, et al. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced endothelial ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 1991;88:20-6.
11. Walsh GM, Mermod JJ, Hartnell A, Kay AB, Wardlaw AJ. Human eosinophil but not neutrophil adherence to IL-1-stimulated human umbilical vein endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. J Immunol 1991;46: 3419-23.
12. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67: 1033-6.
13. Von Adrian UH, Chambers JD, McEvoy LM, Bargatze REF, Arfors K-E, Butcher ED. Two step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte B2 integrins in vivo. Proc Natl Acad Sci USA 1991;88:7538-42.
14. Von Andrian UH, Hansell P, Chambers JD, et al. L-selectin function is required for B2 integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am J Physiol 1992;263;32:H1034-44.
15. Sriramarao P, Von Andrian UH, Butcher EC, Bourdon MA, Broide DH. Eosinophil rolling is mediated by ∝4B1 integrin and L-selectin in vivo. J Immunol 1994;53:4238-46.
16. Berlin C, Bargatze F, Campbell JJ, et al. ∝4 Integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995;80:413-22.
17. Symon FA, Walsh GM, Watson SR, Wardlaw AJ. Eosinophil adhesion to nasal polyp endothelium is p-selectin-dependent. J Exp Med 1994;180:371-6.
18. Bochner BS, Luscinskas FW, Gimbrone MA, et al. Adhesion of human basophils, eosinophils, and neutrophils to IL-1 activated human vascular endothelial cells: contribution of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-6.
19. Kyan Aung U, Haskard DO, Poston RN, Thornhill MH, Lee TH. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 1991;146:521-8.
20. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release TNF alpha, which induces ELAM 1. Proc Natl Acad Sci USA 1991;88:4220-4.
21. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. New Engl J Med 1992;326:298-304.
22. Broide DH, Firestein GS. Endobronchial allergen challenge in asthma. Identification of cellular source of GMCSF by in situ hybridization. J Clin Invest 1991;88:1048-53.
23. Broide D, Lotz M, Cuomo A, Coburn D, Federman E, Wasserman SI. Cytokines in symptomatic asthma airways. J ALLERGY CLIN IMMUNOL 1992;89:958-67.
24. Tepper RI, Levinson DA, Stranger BZ, Campos-Torres J, Abbas AK, Leder P. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 1990;62:457-67.
25. Thornhill M, Haskard DO. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol 1990;145:865-72.
26. Pober JS, Gimbrone MA Jr, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986;137:1893-6.
27. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.
28. Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989;246:1303-6.
29. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990;60:577-84.
30. Bochner BS, Charlesworth EN, Lichtenstein LM, et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. J ALLERGY CLIN IMMUNOL 1990;86:830-9.
31. Montefort S, Feather IH, Wilson SJ, Haskard DO, Lee TH, Holgate ST, Howarth PH. The expression of leukocyteendothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol 1992;7:393-8.
32. Firestein GS, Paine MM, Littman BH. Gene expression (collagenase, tissue inhibitor of metallo-proteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Arthritis Rheum 1991;34:1094-105.
33. Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59:1203-11.
34. Swerlick RA, Lee KH, Li LJ, Sepp NT, Caughman SW, Lawley TJ. Regulation of vascular cell adhesion molecule 1 on human dermal microvascualr endothelial cells. J Immunol 1992;149:698-705.
35. Groves RW, Ross E, Berker JNWN, Ross JS, Camp RDR, MacDonald DM. Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skin. J Invest Dermatol 1992;98:384-7.
36. + T cell infiltration. J Immunol 1992;149:2954-60.
37. Petzeibauer P, Bender JR, Wilson J, Pober JS. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in-situ and in cell culture. J Immunol 1993;151:5062-72.
38. Montefort S, Gratziou C, Goulding D, et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994;93:1411-21.
39. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991;12:404-10.
40. Iademarco MF, Barks JL, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J Clin Invest 1995;95:264-71.